Effect of molecular hydrogen on uterine inflammation during preterm labour.
Tomoko Nakano, Tomomi Kotani, Kenji Imai, Yukako Iitani, Takafumi Ushida, Hiroyuki Tsuda, Hua Li, Akira Iwase, Shinya Toyokuni, Fumitaka Kikkawa · Biomedical reports · 2018
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In mice, H₂ administration also resulted in significantly higher progesterone levels compared with LPS treatment alone (P=0.002). These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in mice. H₂ administration also resulted in significantly higher progesterone levels compared with LPS treatment alone (P=0.002).
What the Researchers Studied
The researchers studied mice. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
H₂ was demonstrated to exert anti‑oxidative and anti‑inflammatory effects in foetal organs following intraperitoneal injection of LPS in rodent models (7‑9). However, the present study included a limitation in that H₂ was administered prior to LPS injection as a preventive protocol. Maternal administration of H₂ may therefore be ineffective in preventing preterm birth associated with acute inflammation, although the effects of maternal H₂ administration on chronic inflammation‑induced preterm birth should be investigated further. H₂ administration also resulted in significantly higher progesterone levels compared with LPS treatment alone (P=0.002). The authors concluded that these results suggest that inflammation-induced changes in the uterus may be ameliorated through maternal H₂ administration.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was mice. The study used a preclinical animal experiment.
Limitations and Safety
Reported limitations: However, the present study included a limitation in that H₂ was administered prior to LPS injection as a preventive protocol.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base. The original scholarly source is available at https://www.spandidos-publications.com/10.3892/br.2018.1082/download.